X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1331) 1331
Publication (91) 91
Book Review (22) 22
Book Chapter (8) 8
Dissertation (4) 4
Book / eBook (3) 3
Conference Proceeding (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
isolated limb perfusion (793) 793
humans (774) 774
oncology (571) 571
male (452) 452
index medicus (447) 447
animals (438) 438
female (381) 381
melphalan (343) 343
surgery (343) 343
melanoma (327) 327
middle aged (277) 277
tumor-necrosis-factor (275) 275
aged (271) 271
adult (226) 226
cancer (225) 225
chemotherapy (210) 210
melanoma - drug therapy (189) 189
chemotherapy, cancer, regional perfusion (183) 183
melphalan - administration & dosage (178) 178
sarcoma (176) 176
interferon-gamma (175) 175
tnf-alpha (168) 168
chemotherapy, cancer, regional perfusion - methods (152) 152
rats (152) 152
perfusion (151) 151
malignant-melanoma (147) 147
factor-alpha (143) 143
treatment outcome (140) 140
extremities (136) 136
tumor necrosis factor-alpha - administration & dosage (136) 136
aged, 80 and over (130) 130
medicine & public health (125) 125
skin neoplasms - drug therapy (117) 117
combined modality therapy (116) 116
melanoma - pathology (113) 113
pharmacology & pharmacy (112) 112
skin neoplasms - pathology (110) 110
necrosis-factor-alpha (105) 105
prognosis (101) 101
mice (100) 100
antineoplastic agents - therapeutic use (98) 98
care and treatment (97) 97
antineoplastic agents, alkylating - administration & dosage (95) 95
hyperthermia, induced (95) 95
sarcoma - drug therapy (95) 95
melanoma - therapy (93) 93
tumor necrosis factor-alpha - therapeutic use (86) 86
antineoplastic agents - administration & dosage (85) 85
radiology, nuclear medicine & medical imaging (83) 83
soft-tissue sarcoma (83) 83
tumor necrosis factor (82) 82
isolated limb infusion (81) 81
melphalan - therapeutic use (76) 76
neoplasm staging (75) 75
surgical oncology (75) 75
antineoplastic combined chemotherapy protocols - therapeutic use (74) 74
in vitro techniques (73) 73
melanoma - secondary (73) 73
soft tissue sarcoma (73) 73
isolated hepatic perfusion (72) 72
toxicity (72) 72
survival rate (70) 70
combination (67) 67
therapy (67) 67
dose-response relationship, drug (65) 65
soft-tissue sarcomas (65) 65
metastasis (64) 64
radiotherapy (64) 64
physiology (63) 63
research (63) 63
skin neoplasms - therapy (63) 63
adolescent (61) 61
medicine, research & experimental (61) 61
analysis (60) 60
neoplasms - drug therapy (60) 60
retrospective studies (60) 60
disease models, animal (59) 59
hyperthermia (59) 59
metastases (58) 58
sarcoma - pathology (58) 58
time factors (58) 58
tumors (58) 58
extremity (56) 56
follow-up studies (54) 54
immunotherapy (54) 54
regional chemotherapy (54) 54
tumor necrosis factor-alpha - pharmacology (54) 54
antineoplastic agents, alkylating - therapeutic use (53) 53
apoptosis (53) 53
biochemistry & molecular biology (53) 53
melanoma - surgery (53) 53
survival (53) 53
health aspects (52) 52
phase-i (52) 52
prognostic-factors (51) 51
antineoplastic combined chemotherapy protocols - administration & dosage (50) 50
sarcoma - therapy (49) 49
cardiac & cardiovascular systems (48) 48
cell biology (48) 48
melanoma - mortality (48) 48
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1262) 1262
German (48) 48
French (23) 23
Spanish (5) 5
Italian (2) 2
Russian (1) 1
Slovenian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Zdravniški Vestnik, ISSN 1318-0347, 02/2016, Volume 85, Issue 1
Isolated limb perfusion is a surgical procedure that can be used to treat an advanced malignant melanoma and soft tissue sarcomas, it is also effective in... 
isolated limb perfusion, melanoma, soft tissue sarcomas, in-transit metastases, cytostatic agents, hyperthermia
Journal Article
European Journal of Cancer, ISSN 0959-8049, 09/2018, Volume 100, pp. 46 - 54
Isolated limb perfusion (ILP) is a well-established treatment for patients with advanced extremity malignancies unsuitable for limb-conserving surgery.... 
Geriatric oncology | Soft-tissue sarcoma | Melanoma | Isolated limb perfusion | SURVIVAL | MULTICENTER | STAGE-III | FACTOR-ALPHA | TUMOR-NECROSIS-FACTOR | ONCOLOGY | ADVANCED MELANOMA | QUALITY-OF-LIFE | MELPHALAN | IPILIMUMAB | Skin | Sarcoma | Health aspects | Mortality | Cancer | Index Medicus
Journal Article
Journal Article
International Journal of Hyperthermia, ISSN 0265-6736, 08/2017, Volume 33, Issue 6, pp. 679 - 683
Journal Article
Journal Article
CANCER, ISSN 0008-543X, 09/2016, Volume 122, Issue 17, pp. 2624 - 2632
The management of locally advanced extremity soft tissue sarcoma of the limbs is challenging, particularly for recurrent tumors and those adjacent to... 
ADJUVANT CHEMOTHERAPY | limb salvage | extremity soft tissue sarcoma | CLINICAL-TRIAL | multimodal therapy | RANDOMIZED-TRIAL | PHASE-II | FACTOR-ALPHA | REGIONAL PERFUSION | isolated limb perfusion | NEOADJUVANT CHEMOTHERAPY | HIGH-GRADE | ONCOLOGY | HIGH-RISK | TNF-ALPHA | recombinant human tumor necrosis factor (rhTNF)
Journal Article
European Journal of Cancer, ISSN 0959-8049, 11/2017, Volume 85, pp. 114 - 121
Angiosarcomas are rare and aggressive soft-tissue sarcomas. The only potential curative treatment is complete surgical excision. This study reports the outcome... 
Cutaneous angiosarcoma of the extremity | Sarcoma | Limb salvage technique | Locally advanced angiosarcoma | Angiosarcoma | ILP | Isolated limb perfusion | RESECTION | IN-TRANSIT METASTASES | CUTANEOUS ANGIOSARCOMA | FACTOR-ALPHA | PACLITAXEL | TUMOR-NECROSIS-FACTOR | MELANOMA | ONCOLOGY | SINGLE-INSTITUTION EXPERIENCE | MELPHALAN | SOFT-TISSUE SARCOMA | Chemotherapy, Cancer, Regional Perfusion - adverse effects | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Young Adult | Netherlands | Melphalan - adverse effects | Time Factors | Amputation | Aged, 80 and over | Adult | Female | Retrospective Studies | Chemotherapy, Cancer, Regional Perfusion - methods | Hemangiosarcoma - secondary | Databases, Factual | Soft Tissue Neoplasms - therapy | Hemangiosarcoma - therapy | Limb Salvage | Soft Tissue Neoplasms - mortality | Risk Factors | Kaplan-Meier Estimate | Proportional Hazards Models | Extremities - pathology | Treatment Outcome | Chemotherapy, Cancer, Regional Perfusion - mortality | Hemangiosarcoma - mortality | Regional Blood Flow | Disease Progression | Hemangiosarcoma - blood supply | Disease-Free Survival | Retreatment | Melphalan - administration & dosage | Soft Tissue Neoplasms - blood supply | Extremities - blood supply | Tumor Necrosis Factor-alpha - adverse effects | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Soft Tissue Neoplasms - pathology | London | Tumor Necrosis Factor-alpha - administration & dosage | Aged | Therapeutics | Homeopathy | Materia medica and therapeutics | Index Medicus
Journal Article
Journal of Surgical Oncology, ISSN 0022-4790, 06/2018, Volume 117, Issue 7, pp. 1447 - 1454
Background This feasibility study presents the results of a new intensive treatment regimen for locally advanced extremity soft tissue sarcomas (ESTS),... 
limb salvage | perfusion | sarcoma | radiation | neoadjuvant treatment | SURGERY | SOFT-TISSUE SARCOMAS | EUROPEAN ORGANIZATION | POSTOPERATIVE RADIOTHERAPY | FACTOR-ALPHA | RADIATION-THERAPY | TUMOR-NECROSIS-FACTOR | EXTERNAL-BEAM RADIOTHERAPY | INTERFERON-GAMMA | ONCOLOGY | ISOLATED REGIONAL PERFUSION | Sarcoma | Radiotherapy | Surgery
Journal Article
European Journal of Oncology Nursing, ISSN 1462-3889, 12/2019, Volume 43, p. 101672
In recent years, the incidence of malignant melanoma has rapidly increased worldwide. Among patients with recurrences, approximately 5% develop in-transit... 
Malignant melanoma | Experiences | Qualitative | Patients | Cancer | Isolated limb perfusion | Content analysis
Journal Article
International Journal of Hyperthermia, ISSN 0265-6736, 10/2017, Volume 33, Issue 7, pp. 862 - 866
Journal Article